Exosens SA (EXENS) Stock Price & News

EXENS:EPA

Exosens SA

€57.10

-1.72%

(-1.00) 1D

Oct 22, 5:35:12 PM GMT+2 · EUR

All symbols

	Symbol	Price	Change	% Change

Next call in 4 days

Tue, Oct 27, 9:00 AM

Fiscal period

Q3 2026

- / -

Revenue / Est. (EUR)

- / 136.70M

Fiscal Q3 2026 earnings call

Waiting for the earnings call

At a glance: upcoming earnings

Insights from the latest news and reports

Previous reportsAll values in EUR

Loading Previous Earnings...

All values in EUR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	108.20M	140.40M	126.53M	126.53M
Cost of goods sold	-	-	47.50M	47.50M
Cost of revenue	-	-	47.50M	47.50M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	-	-	39.64M	39.64M
Operating expense	-	-	62.69M	62.69M
Total operating expenses	-	-	110.19M	110.19M
Operating income	-	-	16.35M	16.35M
Other non operating income	-	-	-192.00K	-192.00K
EBT including unusual items	-	-	12.60M	12.60M
EBT excluding unusual items	-	-	13.33M	13.33M
Income tax expense	-	-	4.93M	4.93M
Effective tax rate	-	-	39.15%	39.15%
Other operating expenses	-	-	-70.00K	-70.00K
Net income	-	-	7.67M	7.67M
Net profit margin	-	-	6.06%	6.06%
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-	-	-3.16M	-3.16M
Net interest expenses	-	-	-3.16M	-3.16M
Depreciation and amortization charges	-	-	23.12M	23.12M
EBITDA	-	-	22.28M	22.28M
Gain or loss from assets sale	-	-	-	-

Finance